FABP7 and glioblastoma: 2.4. Expression Levels of FABP7 and Its Modulated Onco-Immune Drivers Correlate with Clinical Outcomes in LGG and GBM by Promoting the Tumor Infiltration of Immunosuppressive Cell Types